Patents by Inventor Reona Sakemura

Reona Sakemura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210284714
    Abstract: This document provides methods and materials involved in treating cancer. For example, chimeric antigen receptor T cells having reduced levels of GM-CSF are provided. Also provided as methods for making and using chimeric antigen receptor T cells having reduced levels of GM-CSF.
    Type: Application
    Filed: March 22, 2021
    Publication date: September 16, 2021
    Applicants: HUMANIGEN, INC., MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventors: Cameron DURRANT, Dale CHAPPELL, Saad J. KENDERIAN, Michelle J. COX, Reona SAKEMURA
  • Publication number: 20210214723
    Abstract: This document provides methods and materials involved in treating cancer. For example, chimeric antigen receptor T cells having reduced levels of GM-CSF are provided. Also provided as methods for making and using chimeric antigen receptor T cells having reduced levels of GM-CSF.
    Type: Application
    Filed: May 31, 2019
    Publication date: July 15, 2021
    Applicant: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventors: Saad J. KENDERIAN, Rosalie M. STERNER, Michelle J. COX, Reona SAKEMURA
  • Publication number: 20210145830
    Abstract: This document provides methods for determining biological age of mammalian subjects or assessing whether the subjects are aging normally. Also provided herein are methods for determining whether therapeutic treatment or other interventions for reversing or slowing down aging are effective. This document also provides methods and materials for slowing the progression of biological aging.
    Type: Application
    Filed: April 5, 2019
    Publication date: May 20, 2021
    Inventors: Saad J. Kenderian, Neil E. Kay, Reona Sakemura, Steven L. Warner, David J. Bearss, Jason Marc Foulks, Lars Mouritsen, Clifford J. Whatcott